These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10857417)

  • 1. [Antilipemic agents, hypothyroidism, and rhabdomyolysis].
    Pía Iglesias G; Garrido Sanjuán JA; González González C; Sesma Sánchez P
    Rev Clin Esp; 2000 Apr; 200(4):236-7. PubMed ID: 10857417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Muscle toxicity of hypolipidemic agents revealed in hypothyroidism].
    Prudhomme F; Jacotot B
    Presse Med; 2003 Apr; 32(13 Pt 1):603-4. PubMed ID: 12718321
    [No Abstract]   [Full Text] [Related]  

  • 3. Simvastatin, fenofibrate, and rhabdomyolysis.
    Jacob SS; Jacob S; Williams C; Deeg MA
    Diabetes Care; 2005 May; 28(5):1258. PubMed ID: 15855605
    [No Abstract]   [Full Text] [Related]  

  • 4. Fenofibrate-induced rhabdomyolysis in two dialysis patients with hypothyroidism.
    Clouâtre Y; Leblanc M; Ouimet D; Pichette V
    Nephrol Dial Transplant; 1999 Apr; 14(4):1047-8. PubMed ID: 10328516
    [No Abstract]   [Full Text] [Related]  

  • 5. Fenofibrate monotherapy induced rhabdomyolysis.
    Barker BJ; Goodenough RR; Falko JM
    Diabetes Care; 2003 Aug; 26(8):2482-3. PubMed ID: 12882895
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of statins and fibrates in hyperlipidemic patients with neuromuscular disorders.
    Leung NM; Ooi TC; McQueen MJ
    Ann Intern Med; 2000 Mar; 132(5):418-9. PubMed ID: 10691600
    [No Abstract]   [Full Text] [Related]  

  • 7. Rhabdomyolysis and acute renal failure associated with gemfibrozil therapy.
    Górriz JL; Sancho A; Lopez-Martin JM; Alcoy E; Catalán C; Pallardó LM
    Nephron; 1996; 74(2):437-8. PubMed ID: 8893176
    [No Abstract]   [Full Text] [Related]  

  • 8. Fenofibrate-induced rhabdomyolysis in a patient with chronic kidney disease: an unusual presenting feature of hypothyroidism.
    Sousa AA; Kronit HS; Neves Fde A; Amato AA
    Arq Bras Endocrinol Metabol; 2009 Apr; 53(3):383-6. PubMed ID: 19578603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dermatomyositis].
    Glitho S; Boukari L; Mekinian A; Fain O
    Rev Prat; 2013 May; 63(5):626. PubMed ID: 23789485
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thyroid myopathy disclosed by a fibrate].
    Schlienger JL; Goichot B; Grunenberger F; Pradignac A
    Rev Med Interne; 1997; 18(2):169-70. PubMed ID: 9092037
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone scintigraphy of drug-induced rhabdomyolysis: antihyperlipidemia agent.
    Takayama T; Tsuji S; Taki J; Michigishi T; Tonami N
    Clin Nucl Med; 1996 Dec; 21(12):988-9. PubMed ID: 8957627
    [No Abstract]   [Full Text] [Related]  

  • 12. Pancreatitis and rhabdomyolysis associated with lovastatin-gemfibrozil therapy.
    Abdul-Ghaffar NU; el-Sonbaty MR
    J Clin Gastroenterol; 1995 Dec; 21(4):340-1. PubMed ID: 8583121
    [No Abstract]   [Full Text] [Related]  

  • 13. Rhabdomyolysis after cerivastatin-gemfibrozil therapy in an HIV-infected patient with protease inhibitor-related hyperlipidemia.
    Mastroianni CM; d'Ettorre G; Forcina G; Lichtner M; Corpolongo A; Coletta S; Vullo V
    AIDS; 2001 Apr; 15(6):820-1. PubMed ID: 11371708
    [No Abstract]   [Full Text] [Related]  

  • 14. Rhabdomyolysis due to combination therapy with cerivastatin and gemfibrozil.
    Alexandridis G; Pappas GA; Elisaf MS
    Am J Med; 2000 Aug; 109(3):261-2. PubMed ID: 11023440
    [No Abstract]   [Full Text] [Related]  

  • 15. [Unnoticed hypothyroidism and myopathy due to lipid-lowering drugs].
    Gascón Ramón G; Bertomeu Blanch F; Meneu Montoliu V; Fenollosa Tamarit MD
    Aten Primaria; 2001 Apr; 27(6):442-3. PubMed ID: 11334586
    [No Abstract]   [Full Text] [Related]  

  • 16. Hypothyroidism is a predisposing factor for fenofibrate-induced rhabdomyolysis--patient report and literature review.
    Satarasinghe RL; Ramesh R; Riyaaz AA; Gunarathne PA; de Silva AP
    Drug Metabol Drug Interact; 2007; 22(4):279-83. PubMed ID: 18447003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate monotherapy-induced rhabdomyolysis in a patient with type-2 diabetes.
    Cetinkaya R; Uyanik A; Yildirim R; Bilen Y; Keles M
    Indian J Med Sci; 2008 Nov; 62(11):458-9. PubMed ID: 19265237
    [No Abstract]   [Full Text] [Related]  

  • 18. By the way, doctor. I take Pravachol to control my cholesterol, and because of high triglycerides, my doctor wants to add TriCor. But my pharmacist warns against taking both medications. If I don't take TriCor, are there alternatives?
    Komaroff AL
    Harv Health Lett; 2005 Mar; 30(5):8. PubMed ID: 16528800
    [No Abstract]   [Full Text] [Related]  

  • 19. Rhabdomyolysis with simvastatin and nefazodone.
    Thompson M; Samuels S
    Am J Psychiatry; 2002 Sep; 159(9):1607. PubMed ID: 12202291
    [No Abstract]   [Full Text] [Related]  

  • 20. Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tc-99m MDP scintigraphy.
    Trieu J; Emmett L; Perera C; Thanakrishnan K; Van Der Wall H
    Clin Nucl Med; 2004 Dec; 29(12):803-4. PubMed ID: 15545884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.